Aromatase inhibitors for infertility in polycystic ovary syndrome. The beginning or the end of a new era?
A meta-analysis of four trials showed significant advantage in pregnancy and delivery rates with aromatase inhibitors compared with CC in women with PCOS. A recent randomized trial demonstrated no clear benefit.
Polyzos
Nikolaos P
NP
PACMeR (PanHellenic Association for Continual Medical Research), Section of Obstetrics and Gynaecology, Athens, Greece. n.polyzos@gmail.com
Tsappi
Maria
M
Mauri
Davide
D
Atay
Vedat
V
Cortinovis
Ivan
I
Casazza
Giovanni
G
D047072:Aromatase Inhibitors / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy* / Q000209:etiology*; D010062:Ovulation Induction / Q000379:methods / Q000639:trends*; D011085:Polycystic Ovary Syndrome / Q000150:complications*; D011247:Pregnancy
D047072:Aromatase Inhibitors